Editing Propofol (section)

===COVID-19===
{{anchor|COVID-19}}
In March 2021, the U.S. [[Food and Drug Administration]] (FDA) issued an [[emergency use authorization]] (EUA) for ''Propofol‐Lipuro'' 1% to maintain sedation via continuous infusion in people older than sixteen with suspected or confirmed COVID-19 who require mechanical ventilation in an [[intensive care unit]] ICU setting.<ref>{{Cite web |title=Propofol-Lipuro 1% (propofol) Injectable emulsion for infusion – 1,000 mg in 100 ml (10 mg /ml) : Fact Sheet for health Care Providers |url=https://www.bbraunusa.com/content/dam/b-braun/us/website/company/covid-files/210319_Propofol_EUA_Submission_to_FDA_hcp.pdf |access-date=5 March 2022 |website=Bbraunusa.com |archive-date=14 May 2021 |archive-url=https://web.archive.org/web/20210514065329/https://www.bbraunusa.com/content/dam/b-braun/us/website/company/covid-files/210319_Propofol_EUA_Submission_to_FDA_hcp.pdf |url-status=dead }}</ref><ref>{{Cite web |title=Letter RE: Emergency Use Authorization 096 |url=https://www.fda.gov/media/146680/download |access-date=5 March 2022 |website=Fda.gov}}</ref><ref>{{Cite web |title=Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of Propofol-Lipuro 1% Injectable Emulsion for Infusion |url=https://www.fda.gov/media/146681/download |access-date=5 March 2022 |website=Fda.gov}}</ref><ref name="FDA EUA">{{Cite web |title=Emergency Use Authorization |url=https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization |access-date=17 April 2021 |website=U.S. [[Food and Drug Administration]] (FDA)}}</ref> During the public health emergency, it was considered unfeasible to limit Fresenius Propoven 2% Emulsion or Propofol-Lipuro 1% to patients with suspected or confirmed COVID-19, so it was made available to all ICU patients under mechanical ventilation.<ref name="FDA EUA" /> This EUA has since been revoked.<ref>{{cite web |url=https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization-archived-information |title=Emergency Use Authorization--Archived Information |website=FDA |archive-url=https://web.archive.org/web/20231216135744/https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization-archived-information |archive-date=December 16, 2023 |url-status=dead}}</ref>